These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 22999412)
1. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412 [TBL] [Abstract][Full Text] [Related]
2. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma. Wu Q; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH Lung Cancer; 2012 Aug; 77(2):407-14. PubMed ID: 22542705 [TBL] [Abstract][Full Text] [Related]
5. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272 [TBL] [Abstract][Full Text] [Related]
6. [Role of centromere protein H in human gastric cancer cell proliferation]. Quan T; He B; Liu T; Li W; Wu S; Jiang Q; Liu W; Liu H; Xu X Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):265-9. PubMed ID: 22381774 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival. Lu G; Shan T; He S; Ren M; Zhu M; Hu Y; Lu X; Zhang D Oncol Rep; 2013 Nov; 30(5):2238-44. PubMed ID: 23970101 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic relevance of centromere protein A in primary osteosarcoma. Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
11. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of osteopontin expression in human gastric carcinoma. Higashiyama M; Ito T; Tanaka E; Shimada Y Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
15. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells]. Liu P; Wang TS; You SH; Ge HM Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873 [TBL] [Abstract][Full Text] [Related]
16. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898 [TBL] [Abstract][Full Text] [Related]
17. Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Wang B; Li GX; Zhang SG; Wang Q; Wen YG; Tang HM; Zhou CZ; Xing AY; Fan JW; Yan DW; Qiu GQ; Yu ZH; Peng ZH Exp Biol Med (Maywood); 2011 Nov; 236(11):1247-53. PubMed ID: 21998129 [TBL] [Abstract][Full Text] [Related]
18. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Wakana Y; Kasuya K; Katayanagi S; Tsuchida A; Aoki T; Koyanagi Y; Ishii H; Ebihara Y Oncol Rep; 2002; 9(6):1213-8. PubMed ID: 12375022 [TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of TESTIN in primary gastric cancer]. Huang W; Weng DS; Pan ZZ; Pan K; Ding PR; Zhou J; Wang H; Zhang HK; Li JJ; Xia JC Ai Zheng; 2008 Sep; 27(9):984-8. PubMed ID: 18799041 [TBL] [Abstract][Full Text] [Related]
20. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]